Ocrelizumab

Revision as of 20:21, 27 September 2011 by WikiBot (talk | contribs) (Protected "Ocrelizumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Template:Drugbox-mab Ocrelizumab is a humanized anti CD20 monoclonal antibody. It targets mature B lymphocytes. As of May 2007 it is in clinical trials (phase III) for rheumatoid arthritis, multiple sclerosis and lupus erythematosus.

Pills  This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.

Template:Immunosuppressants Template:Humanizedmonoclonals

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Ocrelizumab&oldid=608078"